title: Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.
abstract: Motoneurons are generated in excess during embryonic development of higher vertebrates. In the lumbar spinal cord of the developing rat, about 6000 motoneurons are present at embryonic day 14. These neurons grow out axons which make contact with their target tissue, the skeletal muscle. About 50% of the motoneurons are lost during a critical period from embryonic day 14 until postnatal day 3. This process, which is called physiological motoneuron cell death, has been the focus of research aiming at the identification of neurotrophic factors which regulate motoneuron survival during this developmental period. Motoneuron cell death can also be observed in vitro when the motoneurons are isolated from the embryonic avian or rodent spinal cord. These isolated motoneurons and other types of primary neurons have been a useful tool for studying basic mechanisms underlying neuronal degeneration during development and under pathophysiological conditions in neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). Accumulating evidence from such studies suggests that some specific requirements of motoneurons for survival and proper function may change during development. These findings might be relevant for understanding the pathophysiological processes underlying ALS and thus could contribute to the development of new therapeutic strategies.
authors.affiliation: Institute for Clinical Neurobiology, Würzburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Beck
authors.forename: C
authors.initials: C
authors.lastname: Karch
authors.forename: S
authors.initials: S
authors.lastname: Wiese
authors.forename: M
authors.initials: M
authors.lastname: Sendtner
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000473:pathology*; D000818:Animals; D016923:Cell Death / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D009046:Motor Neurons / Q000473:pathology* / Q000502:physiology; D009414:Nerve Growth Factors / Q000502:physiology / Q000627:therapeutic use*
chemical_list: D009414:Nerve Growth Factors